AMICUS THERAPEUTICS, INC.
FOLDNasdaqMid CapHealthcare
13F Pro Quality Score
47.4/100
Rank #1,782 of 2,962 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.
Revenue Growth
85.2/100
Profitability
36.5/100
Balance Sheet
25.5/100
Earnings Quality
67.2/100
Free Cash Flow
41.3/100
Institutional Flow
2.2/100
Revenue Scale
41.2/100
Dilution Risk
12.6/100
Price Chart
Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)
Key Metrics
Top Institutional Holders
as of Q1 2026$489.89M+4.2%
$230.75M+170.8%
$202.78MNew
$202.44M+21.7%
$202.08MNew
$186.45M-13.1%
$181.62M+1212.4%
$167.10M+142.7%
$127.38M+98.6%
$127.01M-42.4%
Financial Trends
Revenue & Net Income
Earnings Per Share
Loading ratio trend…